
A drug with a 30-year track record as an effective tool for fighting cancer may significantly improve memory and thinking in patients with mild-to-moderate Alzheimer’s disease, new research suggests. Sargramostim (brand name: Leukine) has long been used after cancer treatment to coax a patient’s bone marrow to make more disease-fighting white blood cells. It uses… read on > read on >